Efficacy and safety of treatment of HIV-associated multidrug-resistant tuberculosis. Systematic review and meta-analysis

Efficacy and safety of treatment of HIV-associated multidrug-resistant tuberculosis. Systematic review and meta-analysis

The aim was to conduct a systematic review and meta-analysis of published studies assessing the impact of HIV infection on treatment outcomes and the development of adverse reactions in MDR-TB patients.Material and Methods. We searched for publications using the specified keywords in MEDLINE (PubMed...

Full description

Saved in:

Bibliographic Details
Main Author:	A. V. Kukurika
Format:	Article
Language:	Russian
Published:	Journal Infectology 2025-03-01
Series:	Журнал инфектологии
Subjects:	multidrug-resistant tuberculosis hiv infection treatment efficacy safety
Online Access:	https://journal.niidi.ru/jofin/article/view/1734
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Experience in treating drug-resistant tuberculosis in patients with HIV infection
by: A. I. Gordon, et al.
Published: (2014-12-01)

Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
by: Mahdis Cheraghi, et al.
Published: (2025-03-01)

HIV infection and multiple drug resistant tuberculosis: the frequency of co-infection and treatment efficacy
by: O. V. Filinyuk, et al.
Published: (2021-03-01)

Update on multidrug-resistant tuberculosis preventive therapy toward the global tuberculosis elimination
by: Alberto Matteelli, et al.
Published: (2025-06-01)

Multimodal radiomics integrating deep learning and clinical features for diagnosing multidrug-resistant tuberculosis in HIV/AIDS patients
by: Chang Song, et al.
Published: (2025-06-01)

THE EFFICIENCY OF TREATMENT IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS REGISTERED IN 2010
by: S. A. Sterlikov, et al.
Published: (2014-03-01)

Adverse effects profile of multidrug-resistant tuberculosis treatment in a South African outpatient clinic
by: T.Q. Jacobs, et al.
Published: (2012-12-01)

THE EPIDEMIC SITUATION OF TUBERCULOSIS AND HIV INFECTION IN THE PENITENTIARY FACILITIES OF RUSSIA
by: O. B. Nechaeva, et al.
Published: (2015-03-01)

Tongue Ulcer as a Manifestation of Secondary HIV-Associated Multidrug-Resistant Tuberculosis
by: A. V. Kukurika, et al.
Published: (2022-03-01)

Predictors of unfavourable treatment outcomes for HIV-associated MDR-TB in patients with viral hepatitis C
by: A. V. Kukurika
Published: (2024-07-01)

Multidrug Resistance Tuberculosis in the Context of Co-Infection in Ethiopia: A Systematic Review and Meta-Analysis
by: Bezawit Kassaw Hailu, et al.
Published: (2025-02-01)

Efficiency of surgical treatment of multidrug-resistant Pulmonary Tuberculosis within the DOTS-PLUS program
by: A. K. Strelis, et al.
Published: (2009-02-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Risk Factors for Multidrug-resistant Tuberculosis
by: Cleopas Martin Rumende
Published: (2018-04-01)

Mixed infections and heteroresistance of Mycobacterium tuberculosis among multidrug-resistant tuberculosis in China: a genomic epidemiology study
by: Yanping Liu, et al.
Published: (2025-12-01)

RESULTS OF CHEMOTHERAPY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN THE REGIONS OF THE RUSSIAN FEDERATION
by: V. V. Testov, et al.
Published: (2014-04-01)

Impact of Sociodemographic Factors on the Efficacy of Multidrug-resistant Tuberculosis Therapy in Russia: Retrospective Epidemiological Study
by: Ilia Andreevich Bykov
Published: (2025-07-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)

TUBERCULOSIS IN THE CORRECTIONAL FACILITIES OF RUSSIA IN 2012
by: I. M. Son, et al.
Published: (2014-07-01)

Treatment outcomes and predictors of success for multidrug resistant tuberculosis MDR TB in Ugandan regional referral hospitals
by: Godfrey Barteka, et al.
Published: (2025-04-01)

Effectiveness and Safety of New Chemotherapy Regimens in Patients with HIV-associated MDR TB and Viral Hepatitis C
by: A. V. Kukurika, et al.
Published: (2024-12-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

A Rare Presentation of Acute Multifocal Skeletal Multidrug-resistant Tuberculosis
by: Rahul Puli, et al.
Published: (2023-04-01)

Defects in the statistical accounting of patients with tuberculosis with its multidrug-resistant pathogen
by: V. B. Galkin
Published: (2015-02-01)

CLINICAL CASES OF FOCAL PULMONARY TUBERCULOSIS IN CHILDREN WITH MINIMUM INVOLVEMENT IN MULTIDRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2015-03-01)

Differentiating between Intestinal Tuberculosis and Crohn’s Disease May Be Complicated by Multidrug-resistant Mycobacterium tuberculosis
by: Seung Wook Hong, et al.
Published: (2021-07-01)

BCG Tuberculosis Vaccine: Immunological and Clinical Efficacy in Children Born to HIV-Infected Women
by: N. I. Klevno, et al.
Published: (2018-06-01)

Effectiveness of using Glutamyl-cysteinyl-glycine disodium immunomodulator in patients with destructive multidrug-resistant tuberculosis of lungs
by: A. S. Shalmin, et al.
Published: (2015-08-01)

Long-term results of treatment in multidrug-resistant mycobacterium tuberculosis patients interrupting a chemotherapy cycle
by: A. I. Gaida, et al.
Published: (2014-12-01)

Clinical Efficacy of Comprehensive Probiotic Therapy for Intestinal Dyspepsia Syndrome in Patients with Multiple Drug Resistant Tuberculosis with Co-morbid HIV Infection
by: A. A. Kholodov, et al.
Published: (2022-08-01)

Immediate Outcomes of Surgical Treatment for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis
by: D. B. Giller, et al.
Published: (2024-08-01)

Clinical Efficacy and Safety of Clofazimine in Treatment Regimens for Drug Resistant Tuberculosis (Meta-Analysis)
by: A. I. Gayda, et al.
Published: (2024-05-01)

Experience of application of antitubercular and anti-retrovirus therapy at patients with tuberculosis with HIV infection
by: A. V. Mordyk, et al.
Published: (2014-10-01)

Predictors of failure in treatment according program DOTS-PLUS in patients suffering from multidrug-resistant tuberculosis
by: I. G. Felker, et al.
Published: (2012-08-01)

Tuberculosis Cutis Orificialis of the Oral Cavity in a HIV Positive Patient with Pulmonary Tuberculosis
by: A. V. Kukurika, et al.
Published: (2022-08-01)

Resurgence of multidrug-resistant tuberculosis during the COVID-19 pandemic in Korea
by: Tae Hoon Kim, et al.
Published: (2025-06-01)

Prediction of risk factors associated with the development of multidrug-resistant tuberculosis in patients with tuberculosis
by: Haiyan Chen, et al.
Published: (2025-07-01)

The implications of mutations in multiple genes associated with ethambutol resistance among multidrug-resistant tuberculosis isolates from China
by: Ma-chao Li, et al.
Published: (2025-03-01)

A tuberculosis infection focus and its value in the development of tuberculosis in children
by: V. A. Aksenova, et al.
Published: (2015-01-01)

The course of multidrug-resistant pulmonary tuberculosis in HIV-infected people with COVID-19
by: O. M. Raznatovska, et al.
Published: (2022-09-01)